SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler ($ZS) is trending amidst discussions on its earnings report, with community members debating the significance of the results and forward guidance. While some express optimism, citing strong recurring revenue growth and potential analyst upgrades, others are concerned about valuation and profitability, resulting in a volatile mix of bullish and bearish sentiment. The stock's performance is also being compared to others in the cybersecurity sector, such as $CRWD and $PANW.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) Public Ltd Co - Ordinary Shares - Class A

SMX is experiencing increased attention following news of partnerships and expansion plans, particularly related to traceability solutions. The community is actively discussing the potential for a short squeeze, given the stock's low float and high short borrow fees. However, some traders remain cautious, citing the company's history of reverse stock splits and potential dilution.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending amid debates over its valuation and business practices, with discussions focusing on potential market manipulation and the sustainability of its subprime lending model. Community members are actively sharing opinions on whether the stock is overbought, while others discuss analyst ratings and potential SEC investigations. The stock's significant price swings are fueling speculation about its future direction and comparisons to other high-profile companies.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors debate the company's future following its latest earnings report and pivot towards AI and high-performance computing (HPC). While some are optimistic about Cleanspark's potential in the AI sector, citing its infrastructure and power assets, others express concern over the company's debt and cash burn rate. Discussions also revolve around analyst price target upgrades and the potential for a short squeeze.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid mixed sentiment following its Dreamforce event and long-term revenue targets, with some investors questioning the achievability of these goals. Community discussions involve the company's AI strategy, recent insider selling, and a variety of technical analyses. Additionally, some express concerns regarding management and the stock's underperformance compared to its peers.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending due to positive sentiment surrounding its AI server business, highlighted by strong revenue growth, backlog, and increased AI server shipment guidance. Community members are discussing the company's undervalued status and potential for significant upside, while also noting analyst upgrades and partnerships with major players. Some are suggesting the stock is poised for new all-time highs, driven by the growing demand for AI infrastructure.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending amid discussions of its growth potential in the AI edge computing sector and recent contract wins. Community members are also noting the company's strong book-to-bill ratio and potential for profitability, with some speculating about future acquisitions. Chatter also revolves around institutional ownership and a potentially large military contract, driving optimism despite recent volatility.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending downwards as the community debates the impact of lowered Q4 delivery guidance despite reporting narrower losses and improved margins. Investors are scrutinizing the company's path to profitability and questioning management's projections. Concerns about competition and the company's financial position are also circulating among traders.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending due to positive sentiment following a Morgan Stanley price target hike and anticipation of the company's progress in the hot biotech sector. The community is discussing the potential for new 52-week highs and speculating on partnership deals that could significantly boost the stock's valuation. Community members are weighing the decision to buy more shares or hold.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma is trending as the community discusses its lawsuit alleging stock market manipulation, with retail investors closely watching for a potential squeeze. The company's unique position as a biotech firm with existing revenue streams is also generating buzz. Discussions are focused on the company's ongoing efforts to combat alleged market manipulation and the potential impact of its MS drug development program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference

2seventy bio, Inc. (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming TD Cowen 45th Annual Healthcare Conference on March 5, 2025...

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

2seventy bio, Inc. (Nasdaq: TSVT) today provided full-year Abecma (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). We are pleased to see...

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the third quarter ended September 30, 2024. We are very pleased to report 42% sequential growth in...

2seventy bio Earnings Preview

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can...

TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 2seventy bio, Inc. (2seventy bio or the Company) (NASDAQ: TSVT). Investors who...

2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

2seventy bio Inc

$NVDA

$AAPL

$GOOG/$GOOGL

$MSFT

Which company ends 2025 with the largest market cap?

TSVT
2seventy bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TSVT News

TSVT2seventy bio Inc